I see it like this...
Do you want to invest ahead of the pack and own a piece of the future?
Then it takes time and patience and the risks and uncertainties are greater.
And dd is much more important.
It’s always lonelier and scarier to be an outlier and invest away from the pack.
But that’s how fortunes are made.
Fortune favors the brave.
This little company offers the chance to disrupt the way cancer tumors are treated.
Cancer is one of the fastest growing diseases in the world and the market is huge.
The technology works in canines.
This technology is improved since those great and precise canine results because we now have a more stable and effective cell line triggering the chemotherapy and we know how to put more of these cells inside each cap.
We’ve seen from the canine tests that multi dosing of chemo triggered by cypcaps delivers. It’s reasonable to expect the same in humans.
The delay in submitting an ind and getting this disruptive technology tested in humans is caused by the fda increasing and toughening its regulation of live cell treatments and because of some early failures by the suppliers to our company. And because cell therapies Inds are many times more complex than other medicines that apply for ind status. Those simpler applications take big pharma many years so our timeline is not unreasonable for a new and complex live cell therapy.
And cell therapy is the emerging new frontier of medicin right now. And encapsulation is its holy grail.
Supplier problems are sorted now. We are well on track, have our mcb tested and created by America’s leading cell manufacturer, Eurofins,with flying colors and have added some respected new medical and entrepreneurial team members who are informing and driving the ind process.
Claims that immunotherapy will make cypcaps obsolete underestimate the difficulty and complexity of pancreatic cancer and its genetic make up. (and liver cancer) Surgery is still the only successful strategy we have and cypcaps makes it more likely to succeed. Cycaps are also going to be many times cheaper than these formidably expensive immuno treatments. And have no side effects.
They also offer a solution to an unmet medical need in which patients currently face only death. The perfect scenario for breakthrough therapy once our tests show the same results in humans as in dogs. And those results will come four weeks after treatment.
It’s been argued that many animal trials are not matched in humans but in this case it’s not the medicine being tested but a new delivery method. The mechanics are the same in humans and dogs and we already know that the chemotherapies work in both species. Will the mechanism of triggering the active form of chemo be the same? Yes, without question imho. And this is backed by the earliest phase 1 trials by doctor Lohr with what were then less developed technology and less effective and stable activating cells. And less of them.
To doubt the company is to doubt some of the world’s leading oncologists who have designed the proposed trials. It is to doubt doctors Sher and Hidalgo and Makowka who are committed to the technology. It is to doubt Dr Gerald Crabtree and Professor Gunzburg who have have made this the culmination of their life’s work.
It is to doubt Thomas Yuen who is a highly awarded and respected entrepreneur with a leading edge cell therapy lab with his own team of researchers. He has a history of taking promising new technology and making it commercially very very valuable. No one doubts Mr Yuen’s integrity and he and two of his team have joined forces with pmcb as directors and strategic advisor. Eurofins are America’s leading cell manufacturer and they don’t work with companies that lack credibility.
Dr Linda Sher has a superb track record with medical trials and she has joined us as our medical advisor.
These doctors and businessmen know the industry, they know more about the technology than we ever could and they have put their efforts behind it. That’s good enough for me to dismiss the barrage of uniformed and ill advised criticism you can also find about this company on other sites of the internet.
Our leading experts are voting with their support. There is no better litmus test for the integrity of the company and its disruptive platform technology.
Is it scary being ahead of the pack as an investor and in life? Psychologically that’s a given.
Is that where the big money is made? It is. If you do your dd and get it right.
But you dont make the best returns by arriving late and buying after everyone else has finally found it and driven the price up.
We are all very fortunate to have found this before it’s too well known. Before the value is confirmed.
The ind submission, acceptance and early test results are going to attract mainstream media attention. A good news story about pancreatic cancer will attract so much attention. We are the company that might have saved Aretha Frankilins life. Who isn’t going to run that story when it’s accompanied by great news about our treatment saving lives. Who hasn’t been touched by this horrific disease and who wouldn’t want to read about a brilliant cure twenty years in the making by a tiny team of scientists and a retired lawyer who lost his father to pc and decided to do something about it.
Once the results are out and the story breaks it won’t be too late to buy because when we have proof of concept there will be huge interest for diabetes and more but it won’t be at these prices.
We are a small group of 1200 investors who have found this tiny company early. And can buy it for a fraction of what it will be worth not too many months from here.
It’s been a long and frustrating journey but we are achieving excellent test results and so close to compketing the fdas modules with the best team we’ve ever had.
And we’ll have the chance to say we hoped by investing in a new technology which brought a stop to suffering and death for tens of millions of people world wide.
And then there’s diabetes.
And just to be clear. I have never sold or traded a single share of this company. And I would like to buy more.
And it has tested my patience but I know that patience is what’s required with biotech and fortune favour s the brave.
